Efficacy, Tolerability and Virological Consequences of Long-Term Use of Unboosted Atazanavir Plus 2 NRTIs in HIV-Infected Patients

Publisher： Bentham Science Publishers

E-ISSN： 1873-4251|12|5|339-346

ISSN： 1570-162X

Source： Current HIV Research, Vol.12, Iss.5, 2014-09, pp. : 339-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluation of Boosted and Unboosted Atazanavir Plasma Concentration in HIV Infected Patients

Current HIV Research, Vol. 11, Iss. 8, 2013-12 ,pp. : 642-646

Bentham Science Publishers

Access to resources Recommend Favorite

Risk Factors, CD4 Long-Term Evolution and Mortality of HIV-Infected Patients who Persistently Maintain Low CD4 Counts, Despite Virological Response to HAART

Current HIV Research, Vol. 7, Iss. 6, 2009-11 ,pp. : 612-619

Bentham Science Publishers

Access to resources Recommend Favorite

Safety, Tolerability, and Efficacy of Sofosbuvir Plus Ribavirin in Elderly Patients Infected with Hepatitis C Virus Genotype 2

Digestive Diseases, Vol. 34, Iss. 6, 2016-10 ,pp. : 632-639

Karger

Access to resources Recommend Favorite

Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability

By Préau M. Protopopescu C. Raffi F. Rey D. Chêne G. Marcellin F. Perronne C. Ragnaud J.M. Leport C. Spire B.

AIDS Care, Vol. 24, Iss. 4, 2012-04 ,pp. : 434-443

Routledge Ltd

Access to resources Recommend Favorite

Long-Term Gender-Based Outcomes for Atazanavir/Ritonavir (ATV/r)- Containing Regimens in Treatment-Experienced Patients with HIV

Current HIV Research, Vol. 11, Iss. 4, 2013-06 ,pp. : 333-341

Bentham Science Publishers

Access to resources Recommend Favorite